Related Experiment Video
Updated: Jul 15, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
Two genetic pathways for age-related macular degeneration
Andrew DeWan1, Michael B Bracken, Josephine Hoh
1Department of Epidemiology and Public Health, Yale University, 60 College Street, New Haven, CT 06520, USA.
Genetic variants in complement factor H (CFH) and HTRA1 serine peptidase 1 are linked to age-related macular degeneration (AMD). Further research into these factors may reveal new treatments and prevention strategies for AMD.
Area of Science:
- Genetics
- Ophthalmology
- Immunology
Background:
- Age-related macular degeneration (AMD) is a leading cause of vision loss.
- The pathophysiology of AMD is complex and involves genetic and environmental factors.
- Recent discoveries highlight the roles of specific genetic variants in AMD development.
Purpose of the Study:
- To explore the impact of genetic variants in complement factor H (CFH) and HTRA1 serine peptidase 1 on age-related macular degeneration (AMD).
- To understand the underlying biological mechanisms and potential therapeutic targets for AMD.
Main Methods:
- This study focuses on the genetic associations of specific variants.
- Analysis of the His402 variant of CFH and promoter region changes in HTRA1.
- Investigating the link between these genetic factors and AMD development.
Main Results:
- Strong associations were found between the His402 variant of CFH and AMD.
- Alterations in the promoter region of HTRA1 are also strongly associated with AMD.
- These genetic factors are implicated in the pathophysiology of AMD.
Conclusions:
- The identified genetic variants significantly alter the understanding of AMD pathophysiology.
- These findings open new avenues for pharmacologic management and risk identification for AMD.
- Further research is crucial for developing targeted therapies and preventive measures for AMD.
Related Concept Videos
iPS Cell Differentiation
Alzheimer Disease ll: Pathophysiology
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Genetic Lingo
Photoreceptors and Visual Pathways
